logo
  • Home
  • Investor Relations
    • Information Disclosure
      • Announcement & Notices
      • Prospectus
    • Corporate Governance
    • IR Contact
  • PRESS RELEASE
  • Contact Us
English | 中文版 | 繁版
News Release 07 December, 2020
JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting
News Release 03 November, 2020
Leading Cell Therapy Company JW Therapeutics Lists on Main Board of HKEX
News Release 10 August, 2020
JW Therapeutics and Lyell Immunopharma Announce Collaboration to Advance Solid Tumor Treatment in China
News Release 20 July, 2020
JW Acquires Syracuse Biopharma
News Release 09 June, 2020
JW Therapeutics Completes $ 100 Million Series B Financing
News Release 12 December, 2018
JW Therapeutics announced the grand opening of R&D center in Zhangjiang Science City of Pudong New Area, Shanghai
News Release 10 August, 2018
JW Therapeutics to Build Its First Commercial CAR-T Cell Manufacturing Plant in Suzhou, China
News Release 08 March, 2018
JW Therapeutics Closes $ 90 Million Series A Financing
© 2020 JW Therapeutics
|
沪ICP备10016157号
|
沪公网安备31019002000569号
|
Developed by Euroland IR